|
RINT1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.8770997523585E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.32730049173801E-10 |
| Normal-vs-Stage2 |
5.601600E-04 |
| Normal-vs-Stage3 |
1.1980999525818E-09 |
| Normal-vs-Stage4 |
1.82759999999282E-05 |
| Stage1-vs-Stage2 |
5.280600E-01 |
| Stage1-vs-Stage3 |
5.987600E-02 |
| Stage1-vs-Stage4 |
3.500600E-01 |
| Stage2-vs-Stage3 |
8.231700E-02 |
| Stage2-vs-Stage4 |
2.452800E-01 |
| Stage3-vs-Stage4 |
8.767200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.2394001076882E-10 |
| Normal-vs-AfricanAmerican |
8.18250000000909E-05 |
| Normal-vs-Asian |
3.94820000026996E-07 |
| Caucasian-vs-AfricanAmerican |
9.683800E-01 |
| Caucasian-vs-Asian |
6.219800E-01 |
| AfricanAmerican-vs-Asian |
7.963800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.02730000062223E-08 |
| Normal-vs-Female |
1.64570002070263E-09 |
| Male-vs-Female |
9.919800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.23620000294744E-08 |
| Normal-vs-Age(41-60Yrs) |
4.11900513697105E-11 |
| Normal-vs-Age(61-80Yrs) |
1.10840000000501E-06 |
| Normal-vs-Age(81-100Yrs) |
1.435670E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.243000E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.697000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.719400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.112200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.231600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.405400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.578900E-03 |
| Classical-VS-Follicular |
6.357000E-01 |
| Classical-VS-Other |
6.006200E-01 |
| Classical-VS-Normal |
7.6082999900251E-09 |
| Tall-VS-Follicular |
5.403500E-03 |
| Tall-VS-Other |
3.851600E-01 |
| Tall-VS-Normal |
2.9850000249354E-09 |
| Follicular-VS-Other |
5.489400E-01 |
| Follicular-VS-Normal |
3.50260000000491E-05 |
| Other-VS-Normal |
6.240700E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.02730000062223E-08 |
| Normal-vs-N1 |
9.52499999999912E-05 |
| N0-vs-N1 |
9.418000E-01 |
|
|
